An Evaluation of the Pharmacokinetics and Safety of LIPO-102 in Healthy Volunteers

Neothetics

Status and phase: Completed; Phase 1

Conditions: Subcutaneous Adipose Tissue Reduction

Treatments: Drug: LIPO-102

Study type: Interventional

Funder types: Industry

Identifiers

NCT00918606

LIPO-102-CL-01

Details and patient eligibility

About

An Evaluation of the PK and Safety of LIPO-102 in Healthy Volunteers.

Enrollment: 30 patients

Sex: All

Ages: 18 to 55 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Male and non pregnant female
• 18-55 years old
• Sufficient abdominal fat for injections
• Signed informed consent

Exclusion criteria

• Known hypersensitivity to study drugs
• Treatment with an investigational agent within 30 days before first dose

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

30 participants in 1 patient group

LIPO-102

Experimental group

Treatment:

Drug: LIPO-102